Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132811) titled 'Evaluation, Prediction and Health Economic Analysis of Lecanemab Efficacy Based on Multimodal Digital Behavior and Blood Biomarkers: A Prospective Observational Cohort Study' on Sept. 18.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The first hospital of Shanxi Medical University

Condition: Alzheimers disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Treatment Group and Control Group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341077

Published by HT ...